54Gene

Closed

Precision medicine for Africans and the global population

Lagos, Nigeria · $44.5M raised

Headquarters
Lagos
Employees
11–50
Website
54gene.com
Total Funding
$44.5M
Last Round
$25.0M Series BSep 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

We are an African genomics research, services and development company addressing the need to include under-represented African genomic data in research which could lead to medical breakthroughs and new healthcare solutions worldwide.

Summary

54Gene is a Genomics company based in Lagos, Nigeria. It has raised $44.5M in total across 3 rounds, most recently a $25.0M Series B round in Sep 2021. Investors include Cathay Innovation, Adjuvant Capital and Y Combinator.

Tech & App Stack

20 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2021
$25.0M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Caris Life SciencesIPO

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Irving, United States1001–5000Diagnostics, Genomics
Growth EquityTotal funding$1.5BApr 2025
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Corporate RoundTotal funding$1.1BJan 2015
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

54Gene on Indexed.vc
<a href="https://indexed.vc/companies/54gene"><img src="https://indexed.vc/api/badge/company/54gene" alt="54Gene on Indexed.vc" width="260" height="76" /></a>